Johnson & Johnson Unveils Next-Gen Coronary IVL Catheter
Johnson & Johnson (JNJ) introduced an upgraded intravascular lithotripsy catheter, the Shockwave C2 Aero, designed to treat calcified coronary artery disease. The device features enhanced deliverability and lesion-crossing capabilities, currently available in the US and Japan with plans for expansion.
Tickers: $JNJ